Changes in survival of patients with non–small cell lung cancer in Japan: An interrupted time series study-Reference-Cited by-同舟云学术

Changes in survival of patients with non–small cell lung cancer in Japan: An interrupted time series study

Published:2022-11-30 Issue:3 Volume:114 Page:1154-1164
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Taniyama Yukari¹^ORCID,Oze Isao²^ORCID,Koyanagi Yuriko N.¹^ORCID,Kawakatsu Yukino²,Ito Yuri³^ORCID,Matsuda Tomohiro⁴,Matsuo Keitaro²⁵^ORCID,Mitsudomi Tetsuya⁶^ORCID,Ito Hidemi¹⁷^ORCID

Affiliation:

1. Division of Cancer Information and Control, Department of Preventive Medicine Aichi Cancer Center Research Institute Nagoya Japan

2. Division of Cancer Epidemiology and Prevention, Department of Preventive Medicine Aichi Cancer Center Research Institute Nagoya Japan

3. Department of Medical Statistics, Research & Development Center Osaka Medical and Pharmaceutical University Osaka Japan

4. Division of International Collaborative Research, Center for Public Health Sciences National Cancer Center Tokyo Japan

5. Department of Cancer Epidemiology Nagoya University Graduate School of Medicine Nagoya Japan

6. Division of Thoracic Surgery, Department of Surgery Kindai University Faculty of Medicine Osaka‐Sayama Japan

7. Department of Descriptive Cancer Epidemiology Nagoya University Graduate School of Medicine Nagoya Japan

Funder

Japan Society for the Promotion of Science

Ministry of Health, Labour and Welfare

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15646

Reference42 articles.

1. Assessing the efficacy‐effectiveness gap for cancer therapies: A comparison of overall survival and toxicity between clinical trial and population‐based, real‐world data for contemporary parenteral cancer therapeutics

2. A Primer on Effectiveness and Efficacy Trials

3. Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer

4. Mutations of the Epidermal Growth Factor Receptor Gene in Lung Cancer

5. Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Knockdown of NCAPD3 inhibits the tumorigenesis of non-small cell lung cancer by regulation of the PI3K/Akt pathway;BMC Cancer;2024-04-02

2. SYNGR2 plays a tumor-promoting role in lung adenocarcinoma through PI3K-AKT signaling pathway;2023-10-28

3. Regression of Lung Cancer in Mice by Intranasal Administration of SARS-CoV-2 Spike S1;Cancers;2022-11-17